$103.5M in CY2024 Part D spend65K claims · 14K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Droxidopa used for?
Droxidopa capsules indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic ....
Is there a generic for Droxidopa?
Yes. 33 ANDAs filed at FDA, 11 generic manufacturers currently shipping.
How much does my plan pay for Droxidopa?
Across 329 Part D plans, Droxidopa averages $1.63/unit (NADAC). Lowest available: $0.643/unit. Highest in distribution: $2.75/unit.
Is Droxidopa on the FDA shortage list?
No. Droxidopa is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.